pocketful logo
Bharat Immunological & Biological Corporation Ltd logo

Bharat Immunological & Biological Corporation Ltd

NSE: BSE: 524663

16.72

(0.42%)

Sun, 29 Mar 2026, 05:57 pm

Bharat Immunological & Biological Corporation Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    67.49

  • Net Profit

    -17.06

  • P/B

    -4.09

  • Sector P/E

    39.81

  • P/E

    0

  • EV/EBITDA

    0

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.96

  • ROCE (Industry)

    16.65

  • RONW (Industry)

    14.66

  • ROE

    0

  • ROCE

    0

  • Debt/Equity

    0

  • EPS (TTM)

    0

  • Dividend Yield

    0

  • Book Value

    -7.54

  • Interest Cover

    -2.24

Analysis

all

thumbs up icon

Pros

  • Debt is covered by short term assets, assets are 2x debt.
  • Bharat Immunologicals & Biologicals's cash and other short term assets cover its long term commitments.
  • Bharat Immunologicals & Biologicals had negative shareholder equity 5 years ago, it is now positive therefore their debt level has improved.
  • The tenure for the Bharat Immunologicals & Biologicals board of directors is about average.
  • 524663 outperformed the Biotechs industry which returned 53.2% over the past year.
thumbs up icon

Cons

  • Unable to evaluate Bharat Immunologicals & Biologicals's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Bharat Immunologicals & Biologicals's dividend against the top 25% market benchmark as the company has not reported any payouts.
  • Bharat Immunologicals & Biologicals's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Operating cash flow is negative therefore debt is not well covered.
  • Bharat Immunologicals & Biologicals's level of debt (186.1%) compared to net worth is high (greater than 40%).

Read More

Financials

No Result Found

Read More

Ratios

No Result Found

Read More

Shareholding

ShareholdersMAR 2024SEPT 2023JUN 2023MAR 2023DEC 2022
Promoters59.2559.2559.2559.2559.25
FII00000
DII00000
Public40.7540.7540.7540.7540.75
Government00000

Read More

Technical Analysis

RSI

-

MACD

-

50 DMA

-

200 DMA

-

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic-------
Fibonacci-------
Camarilla-------

Pivots Level: Classic

R3

+-

-

R2

+-

-

R1

+-

-

-
-
Pivot Point
LTP: -

S1

--

-

S2

--

-

S3

--

-

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    -

  • 20-EMA

    -

  • 30-EMA

    -

  • 50-EMA

    -

  • 100-EMA

    -

  • 200-EMA

    -

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
28 Nov 2023agm
20 Sept 2022agm
01 Nov 2021agm

Read More

Peer Comparison

No Result Found

Bharat Immunological & Biological Corporation Ltd logo

Bharat Immunological & Biological Corporation Ltd

Lupin Ltd logo

Lupin Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Read More

Bharat Immunological & Biological Corporation Ltd About

Bharat Immunological & Biolog.Corp. is engaged in the manufacture of Oral polio Vaccine, Zinc Tablets, Diarehha management Kit and BIB Sweet Tablets.(Source : 202303 Annual Report Page No:05)

Industry

Pharmaceuticals - Indian - Formulations

Founded

1989

Headquarters

CEO

Y K Gupta

Employees

Contact

Website icon

Website

http://www.bibcol.com

Email icon

Email

sklalacs@yahoo.co.in

Phone icon

Phone

91-5732-238210

Location icon

Location

BIBCOL OPV Plant Village Chola, , Bulandshahr, Uttar Pradesh, 203203

Read More

Bharat Immunological & Biological Corporation Ltd Company History

YearHistory
2005
  • The company signed a MoU with DBT for the fiscal year.
2006
  • The company secured a place among the Top 20 Bio tech companies in the country through its commendable performance.
2007
  • Sh. N S Samant, Joint Secretary, Department of Biotechnology was appointed as Director of the Company.
  • Shri. S Subbiah was appointed as Managing Director on the Board of Directors.
2011
  • The Company appointed Ms. Sheila Sangwan, Sh. Sreeshan Raghwan and Dr. Y. K. Gupta, as Directors of the Company.
2013
  • BIBCOL bagged the full order of MOHFW for supply of Oral Polio Vaccine for the national immunization programme.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
ARVINDBHAI JETHABHAI MORIBuy30000020.2527 Mar 2025
PRIYA MANAVADARIYASell30000020.2527 Mar 2025
NK SECURITIES RESEARCH PVT. LTD.Buy24892833.7407 Jan 2025
NK SECURITIES RESEARCH PVT. LTD.Sell24892833.807 Jan 2025
PRIYA MANAVADARIYABuy23232730.106 Jan 2025
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDSell34016844.4927 Dec 2022
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDBuy49759044.527 Dec 2022
TOPGAIN FINANCE PRIVATE LIMITEDSell22055944.8523 Dec 2022
TOPGAIN FINANCE PRIVATE LIMITEDBuy22055944.1223 Dec 2022
ALPHA LEON ENTERPRISES LLPSell49618861.0507 Jun 2021

Read More

Bharat Immunological & Biological Corporation Ltd News

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800